Stem is trading 7.55% down at $4.04, with no new company-specific catalyst identified for September 22, 2026.
- August 12 results showed revenue below forecasts despite a narrower adjusted loss.
- Earlier reporting cited cash-burn and debt concerns, which may weigh on sentiment, but available coverage does not directly attribute today’s decline to them.
- Broader markets are mixed, making a global explanation inconclusive.